Cellectar Biosciences, Inc. · NASDAQ:CLRB
Hexstone Capital LLC's stake in Cellectar Biosciences, Inc. fell to 4.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 4, 2026
Hexstone Capital LLC's stake in Cellectar Biosciences, Inc. fell to 4.90%, 216,130 shares, as a passive investor on Dec 31, 2025. Filed Feb 4, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 216,130
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Hexstone Capital LLC | 4.90% | 216,130 |
| Brendan O'Neil | 4.90% | 216,130 |
Source
Related
- Cellectar Biosciences, Inc.
- Hexstone Capital LLC
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Hexstone Capital LLC · Aug 8, 2025
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Bleichroeder LP · Aug 13, 2026